What steps can we take to increase patient participation in clinical trials, particularly among diverse populations?
Gary Puckrein, President and CEO of the National Minority Quality Forum, discusses the importance of diversity in clinical trials at the launch of the new I’m In campaign to increase the number of minority participants in clinical trials. One of the great challenges that we face right now is to get greater diversity […]
JN: 3/16/14 Thousands of volunteers participate in clinical trials across the United States each year, all hoping that the experimental treatment will help ease their pain or cure their disease. While the trials target a host of different ailments, there is one thing most of those patients have in common. The vast majority are white, […]
JAMA: 3/12/14 Importance The discontinuation of randomized clinical trials (RCTs) raises ethical concerns and often wastes scarce research resources. The epidemiology of discontinued RCTs, however, remains unclear. Objectives To determine the prevalence, characteristics, and publication history of discontinued RCTs and to investigate factors associated with RCT discontinuation due to poor recruitment and with nonpublication. Design and Setting Retrospective […]
HHS: March 11, 2014 Network can prepare, conduct clinical studies for drugs to protect health in emergencies HHS today established a network of five clinical research organizations that will design and conduct clinical studies needed to develop medical countermeasures – drugs, vaccines, and diagnostic tests that help protect health against bioterrorism, pandemic influenza, and other public […]
PACE: 03/13/14 Perception poses a huge barrier when it comes to clinical trial participation. While trials remain vital to progress against cancer, less than 5% of U.S. cancer patients enroll in them, due in part to misinformation surrounding the process. Though 71% of Americans agree on the importance of clinical trials, many remain hesitant to participate. In order […]
Prnewswire: 3/12/14 I’m In campaign to educate underrepresented populations about clinical trial participation WASHINGTON, March 12, 2014 /PRNewswire/ — The Pharmaceutical Research and Manufacturers of America (PhRMA) and the National Minority Quality Forum today announced a first-of-its-kind national campaign to help increase diversity in clinical trials. The I’m In campaign will raise awareness about the importance of clinical research and […]
Biomedcentral: 2/26/14 A compelling ethical rationale supports patient engagement in healthcare research. It is also assumed that patient engagement will lead to research findings that are more pertinent to patients’ concerns and dilemmas. However; it is unclear how to best conduct this process. In this systematic review we aimed to answer 4 key questions: what are […]